Effects of hyperacute blood pressure and heart rate on stroke outcomes after intravenous tissue plasminogen activator

Yasuhiro Tomii(National Cerebral and Cardiovascular Center), Kazuo Minematsu(Kishokai Medical Corporation), Takahiro Nakashima(National Cerebral and Cardiovascular Center), Masatoshi Koga(National Cerebral and Cardiovascular Center), Chiaki Yokota(National Cerebral and Cardiovascular Center), Ḱazunori Toyoda(National Cerebral and Cardiovascular Center), Kazuyuki Nagatsuka(United Cerebral Palsy), Tomohisa Nezu(Hiroshima University)
Journal of Hypertension
August 6, 2011
10.1097/hjh.0b013e32834a764e
Cited by 36

Related Papers

Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials
|The Lancet|2014|2.7k
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source
|New England Journal of Medicine|2019|823
JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome
|Circulation Journal|2019|582
Epidemiology, pathophysiology, diagnosis, and management of intracranial artery dissection
|The Lancet Neurology|2015|464
Prevalence, Clinical Features, and Prognosis of Acute Myocardial Infarction Attributable to Coronary Artery Embolism
|Circulation|2015|401